Previous Close | 1.0900 |
Open | 1.0900 |
Bid | 1.0800 x 1400 |
Ask | 1.0900 x 1800 |
Day's Range | 1.0500 - 1.1000 |
52 Week Range | 0.6700 - 2.0400 |
Volume | |
Avg. Volume | 1,143,296 |
Market Cap | 189.185M |
Beta (5Y Monthly) | 0.69 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2100 |
Earnings Date | Nov 01, 2023 - Nov 06, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.17 |
Subscribe to Yahoo Finance Plus to view Fair Value for RIGL
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, will present a company overview at the Cantor Global Healthcare Conference on Wednesday, September 27, 2023 at 3:35 p.m. ET in New York, NY.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, and Dean Schorno, the company's chief financial officer, will participate in the following investor conferences in September:
Q2 2023 Rigel Pharmaceuticals Inc Earnings Call